3 hours Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Sees Significant Drop in Short Interest MarketBeat
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 15,280,000 shares, a decrease of 5.5% from the Au…